FULCRUM THERAPEUTICS, INC. (FULC) Free cash flow 2018–2025
FULCRUM THERAPEUTICS, INC. (FULC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$60.4MFY2025 · since FY2018: -$31.5M → -$60.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$60.4M | -2319.0% |
| FY2024 | -$2.5M | +97.3% |
| FY2023 | -$91.5M | +7.6% |
| FY2022 | -$99.0M | -23.5% |
| FY2021 | -$80.2M | -45.8% |
| FY2020 | -$55.0M | -36.3% |
| FY2019 | -$40.3M | -27.9% |
| FY2018 | -$31.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More FULC financial trends
FULC RevenueFULC Net incomeFULC Net marginFULC Gross profitFULC Gross marginFULC Operating incomeFULC Operating marginFULC Operating cash flowFULC Capital expendituresFULC Return on equityFULC Stock buybacksFULC Dividends paidFULC Total assetsFULC Total liabilitiesFULC Shareholders’ equityFULC overview →